Endonovo Announces Advancement of International “Go to Market” Initiative
19 déc. 2022 09h09 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced an aggressive initiative to introduce and develop the sales and benefits of SofPulse®...